ボーングラフト(骨移植)・代用骨:医療機器パイプライン分析2017

GlobalDataが発行した調査報告書(GDME0451EPD)
◆英語タイトル:Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2017
◆商品コード:GDME0451EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年9月12日
◆ページ数:437
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,356,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Bone Grafts and Substitutes – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Bone Grafts and Substitutes – Medical Devices Pipeline Assessment, 2017″ provides an overview of Bone Grafts and Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Grafts and Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Bone Grafts and Substitutes under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Bone Grafts and Substitutes and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- – Formulate significant competitor information, analysis, and insights to improve R&D strategies
- – Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- – Identify and understand important and diverse types of Bone Grafts and Substitutes under development
- – Develop market-entry and market expansion strategies
- – Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- – In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 18
2 Introduction 19
2.1 Bone Grafts and Substitutes Overview 19
3 Products under Development 20
3.1 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 20
3.2 Bone Grafts and Substitutes – Pipeline Products by Segment 21
3.3 Bone Grafts and Substitutes – Pipeline Products by Territory 22
3.4 Bone Grafts and Substitutes – Pipeline Products by Regulatory Path 23
3.5 Bone Grafts and Substitutes – Pipeline Products by Estimated Approval Date 24
3.6 Bone Grafts and Substitutes – Ongoing Clinical Trials 25
4 Bone Grafts and Substitutes – Pipeline Products under Development by Companies 26
4.1 Bone Grafts and Substitutes Companies – Pipeline Products by Stage of Development 26
4.2 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 30
5 Bone Grafts and Substitutes Companies and Product Overview 34
5.1 Accelerated Orthopedic Technologies, Inc. Company Overview 34
5.2 Adaptaide Inc. Company Overview 35
5.3 Adocia SAS Company Overview 36
5.4 Advanced Biologics LLC Company Overview 39
5.5 Aeon Astron Corporation Company Overview 40
5.6 Agenta Biotechnologies Inc Company Overview 41
5.7 Allegra Orthopaedics Ltd Company Overview 42
5.8 Alphatec Holdings Inc Company Overview 43
5.9 Amend Surgical, Inc. Company Overview 44
5.10 Anika Therapeutics Inc Company Overview 45
5.11 Antibe Therapeutics Inc Company Overview 47
5.12 Aperion Biologics Corp Company Overview 49
5.13 Arthro Kinetics AG Company Overview 54
5.14 Aursos, Inc (Inactive) Company Overview 55
5.15 Baxter International Inc Company Overview 56
5.16 Berkeley Advanced Biomaterials Inc Company Overview 58
5.17 Bio2 Technologies, Inc. Company Overview 60
5.18 Bioactive Bone Substitutes Ltd Company Overview 61
5.19 Bioregeneration Technologies, Inc Company Overview 64
5.20 Bio-Scaffold International Pte Ltd Company Overview 65
5.21 BioSET Inc Company Overview 68
5.22 Bioventus LLC Company Overview 69
5.23 Bone Solutions Inc Company Overview 71
5.24 BoneGrafix, Inc. Company Overview 74
5.25 BoneSupport AB Company Overview 75
5.26 Calcitec, Inc. Company Overview 79
5.27 Carmell Therapeutics Corp Company Overview 80
5.28 CeraPedics Inc Company Overview 81
5.29 Chinese University of Hong Kong Company Overview 82
5.30 Citrics Biomedical, LLC (Inactive) Company Overview 83
5.31 Collagen Solutions Plc Company Overview 84
5.32 CollPlant Ltd Company Overview 85
5.33 Colorado Therapeutics, LLC Company Overview 87
5.34 ConMed Corporation Company Overview 88
5.35 curasan AG Company Overview 89
5.36 Daewoong Pharmaceutical Co Ltd Company Overview 92
5.37 DSM Biomedical BV Company Overview 93
5.38 Element Orthopedics, Inc. Company Overview 94
5.39 ElutInc Company Overview 95
5.40 Ember Therapeutics Inc Company Overview 96
5.41 EpiBone Inc Company Overview 97
5.42 Exactech Inc Company Overview 98
5.43 Ferring Pharmaceuticals A/S Company Overview 99
5.44 Graftoss Limited Company Overview 103
5.45 Graftys SA Company Overview 104
5.46 Inion Oy Company Overview 108
5.47 Innovia LLC Company Overview 109
5.48 Innovoss Inc. Company Overview 110
5.49 Isto Biologics Company Overview 111
5.50 Jellagen Pty Ltd Company Overview 112
5.51 John Hopkins University Company Overview 113
5.52 kasios sas Company Overview 114
5.53 King’s College London Company Overview 116
5.54 Kuros Biosciences AG Company Overview 117
5.55 Kytogenics Pharmaceuticals Inc Company Overview 121
5.56 Lattice Biologics Ltd Company Overview 122
5.57 Maxigen Biotech Inc Company Overview 124
5.58 Medisse BV (Inactive) Company Overview 127
5.59 Medtronic plc Company Overview 128
5.60 Meta Biomed Co Ltd Company Overview 133
5.61 Miromatrix Medical Inc Company Overview 134
5.62 N2 Biomedical Company Overview 135
5.63 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 136
5.64 NovaBone Products LLC Company Overview 137
5.65 Nutech Medical Inc Company Overview 138
5.66 NuVasive Inc Company Overview 139
5.67 Orthocell Ltd Company Overview 142
5.68 Orthogem Company Overview 146
5.69 Orthogen LLC Company Overview 147
5.70 Orthosera GmbH Company Overview 148
5.71 OssiFi, Inc. Company Overview 149
5.72 OsteoNovus, LLC Company Overview 150
5.73 PolyPid Ltd Company Overview 152
5.74 Promimic AB Company Overview 155
5.75 ReCaPP Company Overview 156
5.76 RepRegen Ltd. (Inactive) Company Overview 157
5.77 Revivicor Inc Company Overview 159
5.78 RTI Surgical Inc Company Overview 160
5.79 San Raffaele hospital Company Overview 161
5.80 Scil Technology GmbH Company Overview 162
5.81 SeaSpine, Inc. Company Overview 163
5.82 SIRAKOSS Ltd Company Overview 165
5.83 Sofregen Medical Inc Company Overview 167
5.84 Soft Tissue Regeneration Inc Company Overview 169
5.85 Soteira Inc Company Overview 170
5.86 SurgaColl Technologies Ltd Company Overview 171
5.87 SurGenTec LLC Company Overview 172
5.88 TBF Genie Tissulaire Company Overview 173
5.89 Theragnostic Technologies Inc Company Overview 176
5.90 Tissue Regeneration Systems, Inc. Company Overview 177
5.91 Trinity College Dublin Company Overview 178
5.92 University of California San Diego Company Overview 179
5.93 University of Edinburgh Company Overview 180
5.94 University of Malaya Company Overview 181
5.95 University of Maryland Company Overview 182
5.96 University of Memphis Company Overview 183
5.97 University of Nottingham’s School Of Pharmacy Company Overview 184
5.98 University of Pecs Company Overview 185
5.99 University of South Florida Company Overview 186
5.100 Vericel Corp Company Overview 187
5.101 Wayne State University Company Overview 188
5.102 Wound Management Technologies Inc Company Overview 189
5.103 Wright Medical Group NV Company Overview 190
5.104 X-spine Systems Inc Company Overview 195
5.105 Xtant Medical Holdings Inc Company Overview 196
6 Bone Grafts and Substitutes- Recent Developments 198
6.1 Aug 31, 2017: Bone Therapeutics Appoints Jean-Luc Vandebroek as Chief Financial Officer 198
6.2 Aug 31, 2017: Bone Therapeutics Announces H1 Results for 2017 198
6.3 Aug 29, 2017: Globus Medical Appoints David M. Demski as CEO 200
6.4 Aug 29, 2017: NuVasive Announces World-Class Innovation Center At San Diego Headquarters 200
6.5 Aug 29, 2017: Antibe Therapeutics Reports Q1 2018 Interim Financial and Operating Results 201
6.6 Aug 28, 2017: Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe 202
6.7 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 203
6.8 Aug 25, 2017: Sr-­HT-­Gahnite Bone Substitute Project Update 203
6.9 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 204
6.10 Aug 17, 2017: BONESUPPORT Holding: Interim Report January – June 2017 206
6.11 Aug 15, 2017: NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer 207
6.12 Aug 14, 2017: Governor McAuliffe Announces LifeNet Health to Invest $12.25 million, Create 321 New Jobs in City of Virginia Beach 208
6.13 Aug 14, 2017: aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017Berlin, 14 August 2017 209
6.14 Aug 10, 2017: Alphatec Holdings Reports Second Quarter 2017 Financial Results 210
6.15 Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 212
6.16 Aug 09, 2017: Athersys Reports Second Quarter 2017 Results 213
6.17 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 214
6.18 Aug 08, 2017: RTI Surgical Announces 2017 Second Quarter Results 214
6.19 Aug 07, 2017: Orthofix International Reports Second Quarter 2017 Financial Results 216
6.20 Aug 07, 2017: Bioventus Names Greg Anglum Senior Vice President and Chief Financial Officer, Tony D’Adamio Senior Vice President and General Counsel 217
6.21 Aug 03, 2017: SurGenTec’s GRAFTGUN Receives Core Patent for Post Filling Cages Using Their Graft Delivery Technology 217
6.22 Aug 02, 2017: Globus Medical Reports Second Quarter 2017 Results 218
6.23 Aug 02, 2017: Wright Medical Group Reports 2017 Second Quarter Financial Results 219
6.24 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 221
6.25 Aug 01, 2017: AlloSource Releases AlloFuse Line Extension 222
6.26 Jul 27, 2017: Hoya Reports First Quarter Financial Results 222
6.27 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 223
6.28 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 224
6.29 Jul 27, 2017: Stryker reports second quarter 2017 results 227
6.30 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 228
6.31 Jul 27, 2017: Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue 229
6.32 Jul 27, 2017: NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals 230
6.33 Jul 27, 2017: NuVasive Reports Second Quarter 2017 Financial Results 231
6.34 Jul 26, 2017: Adocia Announces Appointment of Dr. Stanislav Glezer as Chief Medical Officer 232
6.35 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 233
6.36 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 235
6.37 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 236
6.38 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 237
6.39 Jul 25, 2017: Collagen Solutions: Transitioning to accelerated sustainable growth 238
6.40 Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter 245
6.41 Jul 19, 2017: Adocia Presents First Half 2017 Financial Results 245
6.42 Jul 18, 2017: Spineway: Confirmed growth Revenue for the first half of 2017: €6M (+146%) 247
6.43 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 248
6.44 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 248
6.45 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 249
6.46 Jul 11, 2017: Spinal Elements Promotes Jason Blain to President & Chief Operating Officer 249
6.47 Jul 11, 2017: Collagen Solutions: Final Results for the year ended 31 March 2017 250
6.48 Jul 11, 2017: Medicrea Reports First Half 2017 Sales 251
6.49 Jul 06, 2017: Lattice Biologics Announces Change in Director and Chairman of Scientific Advisory Board 251
6.50 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 252
6.51 Jul 03, 2017: Bone Therapeutics Strengthens Board of Directors 252
7 Appendix 432
7.1 Methodology 432
7.2 About GlobalData 435
7.3 Contact Us 435
7.4 Disclaimer 435

1.1 List of Tables
Table 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 22
Table 2: Bone Grafts and Substitutes - Pipeline Products by Segment 23
Table 3: Bone Grafts and Substitutes - Pipeline Products by Territory 24
Table 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 25
Table 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 26
Table 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 27
Table 7: Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development 28
Table 8: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 32
Table 9: Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 10: Cartilage Lesions Repair Device - Product Status 36
Table 11: Cartilage Lesions Repair Device - Product Description 36
Table 12: Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 13: Super-Inductive DBM - Product Status 37
Table 14: Super-Inductive DBM - Product Description 37
Table 15: Adocia SAS Pipeline Products & Ongoing Clinical Trials Overview 38
Table 16: BioChaperone BMP - Degenerative Disc Disease - Product Status 38
Table 17: BioChaperone BMP - Degenerative Disc Disease - Product Description 38
Table 18: Biochaperone BMP - Non-Union Fractures - Product Status 39
Table 19: Biochaperone BMP - Non-Union Fractures - Product Description 39
Table 20: BioChaperone BMP - Osteoporosis - Product Status 39
Table 21: BioChaperone BMP - Osteoporosis - Product Description 40
Table 22: Advanced Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 41
Table 23: OsteoMEM Synthetic Bone Graft Substitute - Product Status 41
Table 24: OsteoMEM Synthetic Bone Graft Substitute - Product Description 41
Table 25: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
Table 26: BioBone Filler - Product Status 42
Table 27: BioBone Filler - Product Description 42
Table 28: Agenta Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 29: B-247 Cranial Bone Graft Implant - Product Status 43
Table 30: B-247 Cranial Bone Graft Implant - Product Description 43
Table 31: Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
Table 32: Sr-HT-Gahnite Bone Substitute - Product Status 44
Table 33: Sr-HT-Gahnite Bone Substitute - Product Description 44
Table 34: Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 35: Bonex - Product Status 45
Table 36: Bonex - Product Description 45
Table 37: Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
Table 38: Biomimetic Bone - Product Status 46
Table 39: Biomimetic Bone - Product Description 46
Table 40: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 41: Hyalobone - Product Status 47
Table 42: Hyalobone - Product Description 47
Table 43: Hyalonect - Product Status 48
Table 44: Hyalonect - Product Description 48
Table 45: Antibe Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 46: CGX-227 - Product Status 49
Table 47: CGX-227 - Product Description 49
Table 48: CGX-443 - Product Status 50
Table 49: CGX-443 - Product Description 50
Table 50: Aperion Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
Table 51: Z-Fix - Product Status 51
Table 52: Z-Fix - Product Description 51
Table 53: Z-Lig BT+ - Product Status 52
Table 54: Z-Lig BT+ - Product Description 52
Table 55: Z-Lig BTB - Product Status 52
Table 56: Z-Lig BTB - Product Description 53
Table 57: Z-Lig ST - Product Status 53
Table 58: Z-Lig ST - Product Description 53
Table 59: Z-Meniscus - Product Status 54
Table 60: Z-Meniscus - Product Description 54
Table 61: Z-Patch - Product Status 54
Table 62: Z-Patch - Product Description 55
Table 63: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 56
Table 64: CaReS plus - Product Status 56
Table 65: CaReS plus - Product Description 56
Table 66: Aursos, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
Table 67: AUR-84 Resorbable Implant - Product Status 57
Table 68: AUR-84 Resorbable Implant - Product Description 57
Table 69: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 70: INDUCTIGRAFT - Product Status 58
Table 71: INDUCTIGRAFT - Product Description 58
Table 72: Synthetic Bone Graft - Orthopaedic - Product Status 59
Table 73: Synthetic Bone Graft - Orthopaedic - Product Description 59
Table 74: Synthetic Bone Graft - Spinal - Product Status 59
Table 75: Synthetic Bone Graft - Spinal - Product Description 59
Table 76: Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 77: CPA Ceramics - Product Status 60
Table 78: CPA Ceramics - Product Description 60
Table 79: HAP Ceramics - Product Status 61
Table 80: HAP Ceramics - Product Description 61
Table 81: Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
Table 82: Hammertoe Intramedullary Fusion Device - Product Status 62
Table 83: Hammertoe Intramedullary Fusion Device - Product Description 62
Table 84: Bioactive Bone Substitutes Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
Table 85: ARTEBONE - Product Status 63
Table 86: ARTEBONE - Product Description 63
Table 87: Bone Graft Substitute - Blocks - Product Status 64
Table 88: Bone Graft Substitute - Blocks - Product Description 64
Table 89: Bone Graft Substitute - Granules - Product Status 64
Table 90: Bone Graft Substitute - Granules - Product Description 65
Table 91: Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 92: InMotion - Product Status 66
Table 93: InMotion - Product Description 66
Table 94: Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
Table 95: BMP And Growth Factor Loaded Scaffold - Orthodontic Oral/Maxillofacial Surgery - Product Status 67
Table 96: BMP And Growth Factor Loaded Scaffold - Orthodontic Oral/Maxillofacial Surgery - Product Description 67
Table 97: BMP And Growth Factor Loaded Scaffold - Orthopaedic Surgery - Product Status 68
Table 98: BMP And Growth Factor Loaded Scaffold - Orthopaedic Surgery - Product Description 68
Table 99: BMP And Growth Factor Loaded Scaffold - Plastic/Reconstructive Surgery - Product Status 68
Table 100: BMP And Growth Factor Loaded Scaffold - Plastic/Reconstructive Surgery - Product Description 69
Table 101: BioSET Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 102: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - Product Status 70
Table 103: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - Product Description 70
Table 104: Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 71
Table 105: OsteoAMP - Concentrate - Product Status 71
Table 106: OsteoAMP - Concentrate - Product Description 71
Table 107: OsteoAMP - Structural - Product Status 71
Table 108: OsteoAMP - Structural - Product Description 72
Table 109: Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Table 110: Osteocrete - Bone Anchor - Product Status 73
Table 111: Osteocrete - Bone Anchor - Product Description 73
Table 112: OsteoCrete - Cranial - Product Status 74
Table 113: OsteoCrete - Cranial - Product Description 74
Table 114: OsteoCrete - Maxillofacial - Product Status 74
Table 115: OsteoCrete - Maxillofacial - Product Description 75
Table 116: OsteoCrete - Non Load Bearing Spine - Product Status 75
Table 117: OsteoCrete - Non Load Bearing Spine - Product Description 75
Table 118: BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
Table 119: Solid Bone Block - Product Status 76
Table 120: Solid Bone Block - Product Description 76
Table 121: BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 77
Table 122: Cerament|G - Product Status 77
Table 123: Cerament|G - Product Description 77
Table 124: BoneSupport AB - Ongoing Clinical Trials Overview 78
Table 125: Cerament|G - A Prospective Clinical Outcome Study of a New Biphasic Absorbable Composite Carrier with Gentamicin in the Treatment of Chronic Osteomyelitis 79
Table 126: Cerament|G - A Prospective, Randomized Multicenter Controlled Trial of CERAMENT|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures 79
Table 127: Cerament|G - CERAMENT lBONE VOID FILLER and gentamicin eluting CERAMENT lG for Prophylactic Use in Bone Tumor Patients 79
Table 128: Cerament|G - CERAMENT/G - Bone Healing and Re-infection Prophylaxis 80
Table 129: Cerament|G - Study to Assess Cerament G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures 80
Table 130: Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
Table 131: Corticell - Product Status 81
Table 132: Corticell - Product Description 81
Table 133: Carmell Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 82
Table 134: Bone Healing Accelerant - DBM Spine - Product Status 82
Table 135: Bone Healing Accelerant - DBM Spine - Product Description 82
Table 136: CeraPedics Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Table 137: i-FACTOR Peptide Enhanced Bone Graft - TLIF - Product Status 83
Table 138: i-FACTOR Peptide Enhanced Bone Graft - TLIF - Product Description 83
Table 139: Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 84
Table 140: Osteoinductive Composite Scaffold - Product Status 84
Table 141: Osteoinductive Composite Scaffold - Product Description 84
Table 142: Citrics Biomedical, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 85
Table 143: CitrOSponge - Product Status 85
Table 144: CitrOSponge - Product Description 85
Table 145: Collagen Solutions Plc Pipeline Products & Ongoing Clinical Trials Overview 86
Table 146: Bone Graft Substitutes - Product Status 86
Table 147: Bone Graft Substitutes - Product Description 86
Table 148: CollPlant Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
Table 149: VergenixBVF - Product Status 87
Table 150: VergenixBVF - Product Description 87
Table 151: VergenixBVF - Antibiotics - Product Status 88
Table 152: VergenixBVF - Antibiotics - Product Description 88
Table 153: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 89
Table 154: Xenograft Implant - Orthopedic - Product Status 89
Table 155: Xenograft Implant - Orthopedic - Product Description 89
Table 156: ConMed Corporation Pipeline Products & Ongoing Clinical Trials Overview 90
Table 157: Allograft Cartilage Scaffold - Product Status 90
Table 158: Allograft Cartilage Scaffold - Product Description 90
Table 159: curasan AG Pipeline Products & Ongoing Clinical Trials Overview 91
Table 160: Cerasorb Classic Ortho - Product Status 91
Table 161: Cerasorb Classic Ortho - Product Description 91
Table 162: Cerasorb M Ortho - Product Status 92
Table 163: Cerasorb M Ortho - Product Description 92

1.2 List of Figures
Figure 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 22
Figure 2: Bone Grafts and Substitutes - Pipeline Products by Segment 23
Figure 3: Bone Grafts and Substitutes - Pipeline Products by Territory 24
Figure 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 25
Figure 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 26
Figure 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 27

【掲載企業】

Accelerated Orthopedic Technologies, Inc.
Adaptaide Inc.
Adocia SAS
Advanced Biologics LLC
Aeon Astron Corporation
Agenta Biotechnologies Inc
Allegra Orthopaedics Ltd
Alphatec Holdings Inc
Amend Surgical, Inc.
Anika Therapeutics Inc
Antibe Therapeutics Inc
Aperion Biologics Corp
Arthro Kinetics AG
Aursos, Inc
Baxter International Inc
Berkeley Advanced Biomaterials Inc
Bio2 Technologies, Inc.
Bioactive Bone Substitutes Ltd
Bioregeneration Technologies, Inc
Bio-Scaffold International Pte Ltd
BioSET Inc
Bioventus LLC
Bone Solutions Inc
BoneGrafix, Inc.
BoneSupport AB
Calcitec, Inc.
Carmell Therapeutics Corp
CeraPedics Inc
Chinese University of Hong Kong
Citrics Biomedical, LLC
Collagen Solutions Plc
CollPlant Ltd
Colorado Therapeutics, LLC
ConMed Corporation
curasan AG
Daewoong Pharmaceutical Co Ltd
DSM Biomedical BV
Element Orthopedics, Inc.
ElutInc
Ember Therapeutics Inc
EpiBone Inc
Exactech Inc
Ferring Pharmaceuticals A/S
Graftoss Limited
Graftys SA
Inion Oy
Innovia LLC
Innovoss Inc.
Isto Biologics
Jellagen Pty Ltd
John Hopkins University
kasios sas
King's College London
Kuros Biosciences AG
Kytogenics Pharmaceuticals Inc
Lattice Biologics Ltd
Maxigen Biotech Inc
Medisse BV
Medtronic plc
Meta Biomed Co Ltd
Miromatrix Medical Inc
N2 Biomedical
National Center of Innovation for Biomaterials in Orthopaedic Research
NovaBone Products LLC
Nutech Medical Inc
NuVasive Inc
Orthocell Ltd
Orthogem
Orthogen LLC
Orthosera GmbH
OssiFi, Inc.
OsteoNovus, LLC
PolyPid Ltd
Promimic AB
ReCaPP
RepRegen Ltd.
Revivicor Inc
RTI Surgical Inc
San Raffaele hospital
Scil Technology GmbH
SeaSpine, Inc.
SIRAKOSS Ltd
Sofregen Medical Inc
Soft Tissue Regeneration Inc
Soteira Inc
SurgaColl Technologies Ltd
SurGenTec LLC
TBF Genie Tissulaire
Theragnostic Technologies Inc
Tissue Regeneration Systems, Inc.
Trinity College Dublin
University of California San Diego
University of Edinburgh
University of Malaya
University of Maryland
University of Memphis
University of Nottingham's School Of Pharmacy
University of Pecs
University of South Florida
Vericel Corp
Wayne State University
Wound Management Technologies Inc
Wright Medical Group NV
X-spine Systems Inc
Xtant Medical Holdings Inc

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ボーングラフト(骨移植)・代用骨:医療機器パイプライン分析2017(Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆